DIRAS3 and glioblastoma: Consistent with the results, K‐M survival curves showed patients with higher expression levels of MAPK8 or STAM had favourable outcomes (Figure S1A,B, P < .05) and patients with higher expression levels of DIRAS3 or LGALS8 had poor prognosis in GBM (Figure S1C,D, P < .05).